Are you Dr. Cullinan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8940 N Wood Sage Rd
Peoria, IL 61615Phone+1 309-243-3000Fax+1 309-243-3050
Summary
- Dr. Stephen Cullinan, MD is an oncologist in Peoria, Illinois. He is currently licensed to practice medicine in Illinois, Tennessee, and Oklahoma. He is affiliated with Carle Health Methodist Hospital.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1975 - 1977
- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1972 - 1974
- University of Illinois College of MedicineClass of 1972
Certifications & Licensure
- IA State Medical License Active through 2014
- IL State Medical License Active through 2014
- CO State Medical License Active through 2013
- GA State Medical License Active through 2013
- IN State Medical License 2001 - 2013
- KY State Medical License Active through 2013
- MI State Medical License Active through 2013
- Join now to see all
Publications & Presentations
PubMed
- 59 citationsProspective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762)Stuart M. Lichtman, Donna Hollis, Antonius A. Miller, Gary L. Rosner, Chris A. Rhoades
Journal of Clinical Oncology. 2006-04-20 - 90 citationsCombination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysisJames N. Ingle, Harry J. Long, Donald I. Twito, Daniel J. Schaid, Stephen A. Cullinan
Cancer. 1991-02-15 - 167 citationsA phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.Stephen A. Cullinan, Charles G. Moertel, Harry S. Wieand, Allan J. Schutt, James E. Krook
Cancer. 1990-05-15